Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6274179 | 0.88 | F10 (0.35) | MAOAMAOB | |
| SCHEMBL6267932 | 0.87 | MAOA (0.42) | MAOA | |
| SCHEMBL6243160 | 0.86 | MAOA (0.45) | MAOAMAOB | |
| SCHEMBL6243152 | 0.86 | MAOA (0.45) | MAOAMAOB | |
| SCHEMBL3041308 | 0.83 | MAOA (0.46) | MAOA | |
| SCHEMBL3028981 | 0.82 | MAOA (0.46) | MAOAMAOB | |
| SCHEMBL3039238 | 0.82 | MAOA (0.46) | MAOA | |
| SCHEMBL3042152 | 0.77 | MAOA (0.51) | MAOA | |
| SCHEMBL6241345 | 0.76 | MAOA (0.42) | MAOA | |
| SCHEMBL3038113 | 0.76 | MAOA (0.38) | MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050288273-A1 | Antibacterial agents | BOYER FREDERICK E JR | 2005-12-29 | — | — | US | disclosed |
| EP-1594865-A2 | ANTIBACTERIAL AGENTS | Warner-Lambert Company LLC (US) | 2005-11-16 | — | — | EP | disclosed |
| WO-2004069832-A2 | ANTIBACTERIAL AGENTS | WARNER-LAMBERT COMPANY LLC (US) | 2004-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288273-A1 | Antibacterial agents | MRPL21, RPN2, FBL | MAOA 236/4885MAOB 221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.